Headlands Research, a clinical trial site network with locations across the United States and Canada, is launching its newest ...
Pharma leaders need to consider the lack of diversity in clinical trial findings and the resulting dearth of therapies ...
Tracey Marantal joins Worldwide Clinical Trials to lead high-performing therapeutic team and drive strategy for growing ...
Clinical trial results from St. Jude Children's Research Hospital demonstrate the benefits of using genomics and early ...
Harvard Medical School professor Joel F. Habener won the 2024 Lasker-DeBakey Clinical Medical Research Award for his work on ...
The introduction of Canadian ethical review services marks a significant expansion of Univo IRB’s capabilities. This ...
The American Lung Association is expanding its work through the Awareness, Trust and Action program to educate Hispanic ...
13h
Sjogren's Syndrome Study: The primary endpoint is to evaluate VELDONA ® in the improvement of saliva secretion and dryness symptoms, with secondary endpoints of EULAR Sjögren's Syndrome Patient ...
UCB and Biogen have announced positive Phase III clinical trial results for PHOENYCS GO study, evaluating dapirolizumab pegol, a new treatment for moderate-to-severe systemic lupus erythematosus (SLE) ...
World Cancer Research Day is a globally recognized movement to raise awareness of the role research plays in the treatment ...
South Florida Biotech Company Seeks To Expand Its Research Program Into Phase 2 Clinical TrialsZEO ScientifiX, Inc. ("ZEO" or ...
17h
Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Foghorn Therapeutics (FHTX – Research Report) yesterday and set a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback